Algert Global’s Sage Therapeutics SAGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,700
| Closed | -$85K | – | 1323 |
|
|
2025
Q1 | $85K | Sell |
10,700
-27,596
| -72% | -$219K | ﹤0.01% | 1137 |
|
|
2024
Q4 | $208K | Sell |
38,296
-104,738
| -73% | -$569K | ﹤0.01% | 1073 |
|
|
2024
Q3 | $1.03M | Buy |
143,034
+78,190
| +121% | +$565K | 0.03% | 741 |
|
|
2024
Q2 | $704K | Buy |
64,844
+39,114
| +152% | +$425K | 0.02% | 782 |
|
|
2024
Q1 | $482K | Hold |
25,730
| – | – | 0.02% | 769 |
|
|
2023
Q4 | $558K | Sell |
25,730
-30,960
| -55% | -$671K | 0.02% | 787 |
|
|
2023
Q3 | $1.17M | Buy |
+56,690
| New | +$1.17M | 0.05% | 533 |
|
|
2023
Q2 | – | Sell |
-14,280
| Closed | -$599K | – | 1231 |
|
|
2023
Q1 | $599K | Sell |
14,280
-10,837
| -43% | -$455K | 0.03% | 778 |
|
|
2022
Q4 | $958K | Sell |
25,117
-8,520
| -25% | -$325K | 0.05% | 588 |
|
|
2022
Q3 | $1.32M | Sell |
33,637
-39,112
| -54% | -$1.53M | 0.08% | 428 |
|
|
2022
Q2 | $2.35M | Buy |
72,749
+54,077
| +290% | +$1.75M | 0.18% | 139 |
|
|
2022
Q1 | $618K | Buy |
18,672
+12,296
| +193% | +$407K | 0.04% | 736 |
|
|
2021
Q4 | $271K | Buy |
6,376
+1,040
| +19% | +$44.2K | 0.03% | 770 |
|
|
2021
Q3 | $236K | Buy |
+5,336
| New | +$236K | 0.03% | 846 |
|
|
2021
Q1 | – | Sell |
-7,310
| Closed | -$632K | – | 518 |
|
|
2020
Q4 | $632K | Sell |
7,310
-21,121
| -74% | -$1.83M | 0.18% | 184 |
|
|
2020
Q3 | $1.74M | Sell |
28,431
-28,727
| -50% | -$1.76M | 0.55% | 48 |
|
|
2020
Q2 | $2.38M | Buy |
57,158
+23,392
| +69% | +$973K | 0.81% | 14 |
|
|
2020
Q1 | $970K | Buy |
+33,766
| New | +$970K | 0.41% | 76 |
|